Eduardo A. M.
- Country
- Spain
- Department
- #7004: Servicio Neurología
Research Overview
- A Phase 1, First-in-Human Study to Evaluate the Safety and Pharmacokinetics of RO7812653 in Patients with Early Symptomatic Alzheimer’s Disease
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE
Data & Insights
Has run more than one trial at 298 of 614 partner sites.
Specializations
Neurodegenerative Disease and Multiple Sclerosis
Clinical research activity in Neurology includes studies in Alzheimer’s disease, mild cognitive impairment, relapsing multiple sclerosis, primary progressive multiple sclerosis, and Parkinson’s disease, with interest in conditions affecting cognition, inflammation, and central nervous system function.
- Alzheimer’s disease
- Relapsing multiple sclerosis
- Parkinson’s disease
Work also extends to brain inflammation, cognitive decline, and neuroimmunology.
Autoimmune, Inflammatory, and Rheumatologic Diseases
The investigator is involved in therapeutic areas centered on systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, Sjögren’s syndrome, and systemic sclerosis, reflecting a strong focus on immune-mediated disease.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Systemic sclerosis
Additional interest includes idiopathic inflammatory myopathy, Behçet’s syndrome, antiphospholipid syndrome, and vasculitic or autoimmune organ involvement.
Oncology and Hematologic Malignancies
Clinical trial involvement spans a broad oncology portfolio, including breast cancer, ovarian cancer, colorectal cancer, urothelial carcinoma, non-small cell lung cancer, renal cell carcinoma, endometrial cancer, and prostate cancer, together with selected hematologic malignancies.
- Breast cancer
- Urothelial carcinoma
- Multiple myeloma
Research also covers lymphoma, acute leukemia, myelodysplastic syndromes, and solid tumors with advanced or metastatic disease.
Cardiometabolic, Renal, and Hepatic Disorders
The investigator’s portfolio includes atherosclerotic cardiovascular disease, heart failure, hypertension, dyslipidemia, obesity, and type 2 diabetes, alongside kidney and liver conditions that require long-term disease control.
- Atherosclerotic cardiovascular disease
- Chronic kidney disease
- Metabolic dysfunction-associated steatohepatitis
Interest also includes IgA nephropathy, focal segmental glomerulosclerosis, liver cirrhosis, and hepatocellular carcinoma.
Dermatology, Gastroenterology, and Infectious Diseases
Additional trial activity involves atopic dermatitis, hidradenitis suppurativa, vitiligo, prurigo nodularis, and chronic spontaneous urticaria, as well as inflammatory bowel conditions such as Crohn’s disease and ulcerative colitis.
- Atopic dermatitis
- Crohn’s disease
- Hidradenitis suppurativa
Infection-related interests include COVID-19, respiratory syncytial virus infection, cytomegalovirus infection, and chronic hepatitis B, together with transplant-associated infectious prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.